VVUS

VIVUS, Inc. News Headlines

$2.61
*  
unch
unch
Get VVUS Alerts
*Delayed - data as of Mar. 2, 2015 9:49 ET  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Orexigen's Q4 Results Disappoint, But Contrave Is Gaining Market Share
2/26/2015 4:39:00 PM - Seeking Alpha


Orexigen: Contrave Scripts Pass 9,000 - Closing In On Qsymia
2/23/2015 11:00:00 AM - Seeking Alpha


Arena: Belviq Sales Show Modest Gain - Time To Assess 2015 Expectations?
2/23/2015 10:33:00 AM - Seeking Alpha


Arena's Belviq Slows At A Bad Time
2/23/2015 9:57:00 AM - Seeking Alpha


What Sarissa Capital's Proxy Fight Means For Ariad Investors
2/23/2015 8:53:00 AM - Seeking Alpha


Orexigen's Contrave Sales Recover - Investors Should Look To Europe
2/18/2015 12:02:00 PM - Seeking Alpha


Arena's Belviq Scripts Spike - Maintaining This Trajectory Important
2/18/2015 9:22:00 AM - Seeking Alpha


Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
2/17/2015 8:03:00 PM - Seeking Alpha


Orexigen's Contrave Resumes Solid Growth Rate
2/17/2015 8:45:00 AM - Seeking Alpha


Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
2/8/2015 12:14:00 AM - Seeking Alpha


Vivus' Qsymia Headed In The Wrong Direction
2/7/2015 5:44:00 AM - Seeking Alpha


Orexigen: Contrave Script Sales Dip. Why?
2/6/2015 6:36:00 PM - Seeking Alpha


Arena Scripts Grow, But Pace Is Slower Than Needed
2/6/2015 6:31:00 PM - Seeking Alpha


Arena's Belviq Keeps Up Momentum During A Flat Week
2/6/2015 4:05:00 PM - Seeking Alpha


With Flat Qsymia Sales, Vivus May Shift Focus To Stendra/Spedra
2/3/2015 2:44:00 PM - Seeking Alpha


Orexigen's Contrave Prescription Growth Slowing, But Still Good
2/2/2015 6:37:00 PM - Seeking Alpha


Arena Pharmaceuticals' Belviq Set To Surge In 2015
2/2/2015 1:47:00 PM - Seeking Alpha


Arena's Belviq Conquers MLK Week According To Symphony
2/2/2015 8:38:00 AM - Seeking Alpha


Gallup Says Obesity Rates Climb Again - Can Anti-Obesity Companies Cash In?
1/28/2015 11:49:00 AM - Seeking Alpha


Contrave Scripts Continue Increases For Orexigen
1/27/2015 3:33:00 PM - Seeking Alpha


What Investors Should Do About Imminent Obesity Drug Approvals In Europe
1/27/2015 8:38:00 AM - Seeking Alpha


Arena's Belviq Prescriptions Fall: More Publicity Is Needed
1/23/2015 2:17:00 PM - Seeking Alpha


Novo Nordisk Receives Positive Opinion In Europe On Obesity Treatment
1/23/2015 12:32:00 PM - Seeking Alpha


Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog
1/22/2015 4:00:00 AM - Investopedia


Vivus Gets New 10% Stakeholder: What To Watch For
1/12/2015 4:31:00 PM - Seeking Alpha